CoreAge Rx Debuts Spot On Prescription Treatment to Target Stubborn Dark Spots and Hyperpigmentation 

 Breaking News
  • No posts were found

CoreAge Rx Debuts Spot On Prescription Treatment to Target Stubborn Dark Spots and Hyperpigmentation 

July 30
00:55 2026
Targeted topical merges Hydroquinone, Kojic Acid, and Niacinamide to improve tone clarity and fade discoloration.

Telehealth provider CoreAge Rx today announced the launch of Spot On, a prescription-strength topical formulation specifically engineered to address hyperpigmentation, sun damage, and post-inflammatory marks. Designed as a localized corrective treatment, the new addition to the CoreAge Rx dermatology portfolio provides a direct approach for individuals seeking to achieve a clearer, more even skin tone.

At the center of the Spot On formulation is Hydroquinone, a clinically proven depigmenting agent that works directly on hyperpigmented areas to lighten dark spots. To reinforce the brightening process, the compound includes Kojic Acid, which helps inhibit melanin production and restore skin clarity. Niacinamide completes the active blend by soothing localized inflammation, reinforcing the skin’s moisture barrier, and enhancing overall skin texture.

Unlike general facial creams, Spot On is formulated strictly for spot application on hyperpigmented areas. Patients apply a small amount to clean, dry skin as directed by their healthcare provider. Due to the high potency of its active ingredients, clinicians typically recommend using the treatment for targeted intervals rather than continuous long-term application. Daily broad-spectrum sunscreen use and sun avoidance are strongly emphasized during the treatment period to prevent recurring discoloration.

Patients can request access to Spot On through the CoreAge Rx digital platform via a completely remote consultation process. After completing a secure online health questionnaire, the submission is evaluated by a US board-certified physician. Upon clinical approval, the tailored prescription is compounded in an American pharmacy and delivered directly to the patient’s residence. CoreAge Rx offers the program starting at $54.99 per month, which includes ongoing provider check-ins and free shipping without mandatory subscriptions or hidden fees.

The introduction of Spot On reflects CoreAge Rx’s ongoing commitment to delivering accessible, physician-backed dermatological care. Patients benefit from continuous access to medical support and online resources throughout their treatment journey.

To learn more about how multi-tiered ingredients target discoloration, read the feature on A Modern Approach to Hyperpigmentation: How CoreAge Rx Is Reimagining Targeted Skincare.

Learn more at https://www.coreagerx.com/product/spot-on

About CoreAge Rx

CoreAge Rx is a digital health platform that connects patients with licensed physicians and manages direct-to-home delivery of prescription treatments and health solutions. By streamlining virtual care across weight management, longevity, and specialized dermatology, CoreAge Rx provides convenient, affordable healthcare designed for modern lifestyles.

For more information, visit coreagerx.com

Media Contact
Company Name: CoreAge Rx
Contact Person: Ella Jones
Email: Send Email
Phone: +1 940-400-4927
City: Wichita Falls
State: TX
Country: United States
Website: www.coreagerx.com